Use of a quantitative real-time reverse transcription-polymerase chain reaction method to study the induction of CYP1A, CYP2B and CYP4A forms in precision-cut rat liver slices
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 32 (9) , 739-747
- https://doi.org/10.1080/00498250210147115
Abstract
1. The aim was to employ real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) technology (TaqMan ®) to examine the induction of some selected cytochrome P450 (CYP) forms in precision-cut rat liver slices. 2. Taqman ® primers and probe sets were developed for rat CYP1A1, CYP1A2, CYP2B1 and CYP4A1 forms. 3. Rat liver slices were cultured in control medium or medium containing either 10 µg ml -1 Aroclor 1254 (ARO), 500µM sodium phenobarbitone (NaPB) or 50µM Wy-14,643 (WY) for 3, 6 and 24 h. 4. Compared with control liver slices, treatment with ARO for 3 and 6 h produced 24- and 184-fold increases, respectively, in CYP1A1 mRNA levels, and after 24h produced an 85-fold increase in CYP1A2 mRNA levels. Levels of CYP1A1 and CYP1A2 mRNA were not markedly affected by NaPB and WY. 5. Treatment with ARO and PB for 24 h produced 10.6- and 23.8-fold increases, respectively, in CYP2B1 mRNA. Levels of CYP2B1 mRNA were not markedly affected by WY. 6. Treatment with WY, but not ARO and NaPB, for 24h produced a 20.4-fold increase in levels of CYP4A1 mRNA. 7. These results demonstrate that cultured liver slices may be used to evaluate the effect of xenobiotics on CYP form mRNA levels.Keywords
This publication has 21 references indexed in Scilit:
- Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytesAdvanced Drug Delivery Reviews, 1996
- Real time quantitative PCR.Genome Research, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slicesXenobiotica, 1996
- Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotionPharmacology & Therapeutics, 1996
- Mechanisms of Hepatocarcinogenicity of Peroxisome-Proliferating Drugs and ChemicalsAnnual Review of Pharmacology and Toxicology, 1995
- Counting target molecules by exponential polymerase chain reaction: Copy number of mitochondrial DNA in rat tissuesBiochemical and Biophysical Research Communications, 1992
- Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liverMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Enzyme induction in the cytochrome P-450 systemPharmacology & Therapeutics, 1990
- Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbituratesCarcinogenesis: Integrative Cancer Research, 1987